Arphra/Issuer/GUFICBIO.NS

GUFICBIO.NS

Gufic Biosciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRCountry macro →

$349.15

Jun 02, 2026

AI Brief

Revenue · FY

$9.44B

Net income

$642.15M

FY 2026

EPS · diluted

$6.40

EBITDA

$1.51B

Explain this page

Arphra AIPlain-English read on Gufic Biosciences Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Insider · 30d

Bought

0 txns

Sold

0 txns

Net flow

+$0

Full history →

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$349.15

Change

+15.61%

Period high

$349.15

Period low

$273.50

Period start

$302.002026-02-01

Through 2026-06-02

Peers

No peer list available for GUFICBIO.NS.

Fair value

Football field →

Weighted blend

$138.99

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Total assets

$13.42B

Total debt

$4.05B

Cash & equiv

$762.17M

Operating CF

$131.71M

Free cash flow

-$180.11M

Buybacks

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for GUFICBIO.NS.

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$9.44B	$1.21B	$642.15M	$6.40	+6.80%